$LIXT News Article - LIXTE Biotechnology and the S
Post# of 74540
(Total Views: 89)
Posted On: 06/07/2023 8:40:46 AM
$LIXT News Article - LIXTE Biotechnology and the Spanish Sarcoma Group Enroll First Patient in a Phase 1b/2 Randomized Trial of Doxorubicin +/- LIXTE's Lead Anti-Cancer Compound, LB-100, in Advanced Soft Tissue Sarcomas https://marketwirenews.com/news-releases/lixt...15859.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼